Clinical Trial Update: Vatalanib in Treating Patients With Metastatic Cutaneous Melanoma That Cannot be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of vatalanib for metastatic cutaneous melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Vatalanib (vatalanib)

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED